CD40 is necessary for activation of naïve T cells by a dendritic cell line in vivo but not in vitro

Scandinavian Journal of Immunology

Volumn 59, Issue 3, 2004, Pages 237-245

  Haase, C ^a   Michelsen, B K ^a   Jorgensen T N ^a,b  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENEIC RESTRICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC;

EID: 1842505275     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01390.x     Document Type: Article

References (43)

1. Grimaldi JC, Torres R, Kozak CA et al. Genomic structure and chromosomal mapping of the murine CD40 gene. J Immunol 1992;149:3921-6.
2. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998;16:111-35.
3. Renshaw BR, Fanslow WC, Armitage RJ et al. Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 1994;180: 1889-900.
4. Xu J, Foy TM, Laman JD et al. Mice deficient for the CD40 ligand. Immunity 1994;1:423-31.
5. Kawabe T, Naka T, Yoshida K et al. The immune responses in CD40-deficient mice: impaired immunoglobulin dass switching and germinal center formation. Immunity 1994;1:167-78.
6. Grewal IS, Xu J, Flavell RA. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995;378:617-20.
7. + T-cell responses. Immunol Today 1996;17:410-4.
8. Peguet-Navarro J, Dalbiez-Gauthier C, Rattis FM et al. Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol 1995;155:4241-7.
9. Kiener PA, Moran-Davis P, Rankin BM et al. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 1995;155:4917-25.
10. Cella M, Scheidegger D, Palmer-Lehmann K et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-52.
11. Buhlmann JE, Foy TM, Aruffo A et al. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 1995;2:645-53.
12. Noelle RJ. CD40 and its ligand in host defense. Immunity 1996;4:415-9.
13. Hollander GA, Castigli E, Kulbacki R et al. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice. Proc Natl Acad Sci USA 1996;93:4994-8.
14. Evans DE, Munks MW, Purkerson JM, Parker DC. Resting B lymphocytes as APC for naive T lymphocytes. Dependence on CD40 ligand/CD40. J Immunol 2000;164:688-97.
15. Wu Y, Xu J, Shinde S et al. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr Biol 1995;5:1303-11.
16. Stout RD, Suttles J, Xu J, Grewal IS, Flavell RA. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 1996;156:8-11.
17. + T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur J Immunol 1994;24:3148-54.
18. Koch F, Stanzl U, Jennewein P et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 1996; 184:741-6.
19. Kato T, Yamane H, Nariuchi H. Differential effects of LPS and CD40 ligand stimulations on the induction of IL-12 production by dendritic cells and macrophages. Cell Immunol 1997;181:59-67.
20. Morelli AE, Zahorchak AF, Larregina AT et al. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood 2001;98:1512-23.
21. + T cells. J Immunol 1997;159:591-8.
22. Jorgensen TN, Haase C, Michelsen BK. Treatment of an immortalized APC cell line with both cytokines and LPS ensures effective T cell activation in vitro. Scand J Immunol 2002;56:492-503.
23. Mach F, Schonbeck U, Sukhova GK et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997;94:1931-6.
24. + T cell tolerance and linked suppression. J Immunol 1999;163:4805-10.
25. De Jong YP, Comiskey M, Kalled SL et al. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration. Gastroenterology 2000;119:715-23.
26. + T cells by blocking the CD40-CD154 interactions. J Immunol 2000;164:6005-14.
27. Griggs ND, Agersborg SS, Noelle RJ et al. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J Exp Med 1996;183:801-10.
28. Carayanniotis G, Masters SR, Noelle RJ. Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 1997;90:421-6.
29. Howard LM, Miga AJ, Vanderlugt CL et al. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD 154) antibody in an animal model of multiple sclerosis. J Clin Invest 1999;103:281-90.
30. Balasa B, Krahl T, Patstone G et al. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol 1997;159:4620-7.
31. Jensen J, Serup P, Karlsen C, Nielsen TF, Madsen OD. mRNA profiling of rat islet tumors reveals nkx 6.1 as a beta-cell-specific homeodomain transcription factor. J Biol Chem 1996;271:18749-58.
32. Caux C, Vanbervliet B, Massacrier C et al. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 1994;180:1841-7.
33. + T cells. J Immunol 1999;162:3256-62.
34. Campos-Neto A, Ovendale P, Bement T et al. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J Immunol 1998;160:2037-41.
35. Zhou P, Seder RA. CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum. J Exp Med 1998;187:1315-24.
36. Campbell KA, Ovendale PJ, Kennedy MK et al. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996;4:283-9.
37. Dekaris I, Zhu SN, Dana MR. TNF-alpha regulates corneal Langerhans cell migration. J Immunol 1999;162:4235-9.
38. Moodycliffe AM, Shreedhar V, Ullrich SE et al. CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J Exp Med 2000; 191:2011-20.
39. Cumberbatch M, Dearman RJ, Antonopoulos C, Groves RW, Kimber I. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha-and IL-1beta-dependent mechanism. Immunology 2001;102:323-30.
40. de Gruijl TD, Luykx-de Bakker SA, Tillman BW et al. Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. J Immunol 2002;169:5322-31.
41. Wang B, Fujisawa H, Zhuang L et al. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol 1997;159:6148-55.
42. Cumberbatch M, Dearman RJ, Kimber I. Langerhans cell migration in mice requires intact type I interleukin 1 receptor (IL-1RI) function. Arch Dermatol Res 1999;291:357-61.
43. Zhang W, Chen Z, Li F et al. Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha. Immunology 2003;108:177-88.